Phoenix Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Phoenix Financial's BIIB Position: Q2 2026 in Review
Phoenix Financial increased its Biogen (BIIB) stake by 6.3% in Q2 2026, buying an estimated $16.5K and bringing the position to 1,457 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #422.
Phoenix Financial first reported a position in BIIB in Q1 2020 and has held it in 13 quarters since. The position peaked at $2.33M in Q3 2020. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Phoenix Financial held 1,457 shares of Biogen worth $315K as of Q2 2026.
- Phoenix Financial bought 86 Biogen shares in Q2 2026, an estimated $16.5K.
- Biogen made up ﹤0.01% of Phoenix Financial's portfolio in Q2 2026, its #422 holding.
- Phoenix Financial first reported a position in Biogen in Q1 2020 and has held it in 13 quarters since.
- Phoenix Financial's Biogen position peaked at $2.33M in Q3 2020.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.